Suppression of early stages of neoplastic transformation in a two-stage chemical hepatocarcinogenesis model: Supplementation of vanadium, a dietary micronutrient, limits cell proliferation and inhibits the formations of 8-hydroxy-2′-deoxyguanosines and DNA strand-breaks in the liver of Sprague-Dawley rats

Nutrition and Cancer

Volumn 59, Issue 2, 2007, Pages 228-247

  Chakraborty, Tridib ^a   Chatterjee, Amrita ^a   Rana, Ajay ^b   Rana, Basabi ^b   Palanisamy, Ashokumar ^a   Madhappan, Rajkumar ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

^b TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM VANADATE; BROXURIDINE; DEOXYGUANOSINE DERIVATIVE; DNA; GLUCOSE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; N (2 FLUORENYL)ACETAMIDE; URIDINE DIPHOSPHATE; VANADIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CANCER STAGING; CELL COUNT; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER TUMOR; LIVER WEIGHT; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STATISTICAL ANALYSIS; TREATMENT DURATION;

RATTUS;

EID: 36849091484     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701615405     Document Type: Article

References (67)

1. Hopkins LL Jr. and Mohr HE: The biological essentiality of vanadium. In Newer Trace Elements in Nutrition, Mertz W and Cornatzer WE (eds.). New York: Marcel Dekker, 1971, pp. 195-213.
2. French RJ and Jones PJ: Role of vanadium in nutrition: metabolism, essentiality and dietary consideration. Life Sci 52, 339-346, 1993.
3. Nielsen FH and Uthus EO: The essentiality and metabolism of vanadium. In Vanadium in Biological Systems, Chasteen ND (ed.). Dordrechlt, The Netherlands: Kluwer Academic Publishers, 1980, pp. 51-62.
4. Stern A, Yin X, Tsang SS, Davidson A, and Moon AJ: Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 71, 103-112, 1993.
5. Elberg G, La J, and Shechter Y: Mechanism of action of vanadium in mediating the biological effects of insulin. In Vanadium in the Environment, Part 2, Nriagu JO (ed.). New York: Wiley-Interscience, 1998, pp. 277-296.
6. Kopf-Maier P and Kopf H: Transition and main-group metal cyclopentadienyl complexes: preclinical studies on a series of antitumor agents of different structural type. Struct Bond 70, 103-185, 1988.
7. Murthy MS, Rao LN, Kuo LY, Toney JH, and Marks TJ: Antitumor and toxicologic properties of the organometallic anticancer agent vanadocene dichloride. Inorg Chim Acta 152, 117-124, 1988.
8. Köpf-Maier P: Complexes of metals other than platinum as anti-tumour agents. Eur J Clin Pharmacol 47, 1-16, 1994.
9. Navara CS, Benyumov A, Vassilev A, Narla RK, Ghosh P, et al.: Vanadocenes as potent anti-proliferative agents disrupting mitotic spindle formation in cancer cells. Anticancer Res 12, 369-376, 2001.
10. D'Cruz OJ and Uckun FM: Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity. Expert Opin Investig Drugs 11, 1829-1836, 2002.
11. Tatematsu M, Nagamine Y, and Farber E: Stable phenotypic expression of glutathione-S-transferase placental type and unstable phenotypic expression of γ-glutamyl transpeptidase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis 9, 215-220, 1988.
12. Farber E: Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Res 44, 5463-5474, 1984.
13. Bitsch A, Klohn PC, Hadjiolov N, Bergmann O, and Neumann HG: New insights into carcinogenesis of the classical model arylamine 2-acetylaminofluorene. Cancer Lett 143, 223-227, 1999.
14. Neumann HG, Hammerl R, Hillesheim W, and Wildschutte M: Role of genotoxic and nongenotoxic effects in multistage carcinogenicity of aromatic amines. Environ Health Perspect 88, 207-211, 1990.
15. Bitsch A, Hadjiolov N, Klohn PC, Bergmann O, Zwirner-Baier I, et al.: Dose response of early effects related to tumor promotion of 2-acetylaminofiuorene. Toxicol Sci 55, 44-51, 2000.
16. Sarkar A, Mukherjee B, and Chatterjee M: Inhibitory effect of β-carotene on chronic 2-acetylaminofiuorene induced hepatocarcinogenesis in rat: reflection in hepatic drug metabolism. Carcinogenesis 15, 1055-1060, 1994.
17. Farber E: The multistep nature of cancer development. Cancer Res 44, 4217-4223, 1984.
18. Pitot HC: Altered hepatic foci: their role in murine carcinogenesis. Ann Rev Pharmacol Toxicol 30, 465-500, 1990.
19. Lindahl T: Instability and decay of the primary structure of DNA. Nature 362, 709-715, 1993.
20. Kasai H: Analysis of a form of oxidative DNA damage, 8-hydroxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387, 147-163, 1997.
21. Nakae D, Kobayashi Y, Akai H, Andoh N, Satox H, et al.: Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res 57, 1281-1287, 1997.
22. Shen HM, Ong CN, Lee BL, and Shi CY: Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis 16, 419-422, 1995.
23. Jia G, Tohyama C, and Sone H: DNA damage triggers imbalance of proliferation and apoptosis during development of preneoplastic foci in the liver of Long-Evans Cinnamon rats. Int J Oncol 21, 755-761, 2002.
24. Bishayee A and Chatterjee M: Time course effects of vanadium supplement on cytosolic reduced glutathione level and glutathione S-transferase activity. Biol Trace Elem Res 48, 275-285, 1995.
25. Bishayee A and Chatterjee M: Inhibition of altered liver cell foci and persistent nodule growth by vanadium during diethylnitrosamine induced hepatocarcinogenesis in rat. Anticancer Res 15, 455-462, 1995.
26. Bishayee A, Roy S, and Chatterjee M: Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamine-induced chemical rat liver carcinogenesis. Oncol Res 11, 41-53, 1999.
27. Bishayee A, Banik S, Marimuthu P, and Chatterjee M: Vanadium-mediated suppression of diethylnitrosamine-induced chromosomal aberrations in rat hepatocytes and its correlation with induction of hepatic glutathione and glutathione S-transferase. Int J Oncol 102, 413-423, 1997.
28. Chakraborty T, Ghosh S, Datta S, Chakraborty P, and Chatterjee M: Vanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis. J Exp Ther Oncol 3, 346-362, 2003.
29. Umemura T, Tokumo K, Sirma H, Gebhardt R, Poirier MC, et al.: Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett 73, 1-10, 1993.
30. Tokumo K, Umemura T, Sirma H, Gebhardt R, Poirier MC, et al.: Inhibition by gonadectomy of effects of 2-acetylaminofluorene in livers of male, but not female rats. Carcinogenesis 14, 1747-1750, 1993.
31. Williams GM, Iatropoulos MJ, and Jeffrey AM: Thresholds for the effects of 2-acetylaminofluorene in rat liver.Toxicol Pathol 32, 85-91, 2004.
32. Moreno FS, Rizzi MBSL, Dagli MLZ, and Penteado MVC: Inhibitory effects of β-carotene on preneoplastic lesions induced in Wistar rats by the resistant hepatocyte model. Carcinogenesis 12, 1817-1822, 1991.
33. Bannasch P: Cytology and cytogenesis of neoplastic (hyperplastic) hepatic nodules. Cancer Res 36, 2555-2562, 1976.
34. Stewart HL, Williams GM, Keysser CH, Lombard LS, and Montail RJ: Histological typing of liver tumors of the rat. J Natl Cancer Inst 64, 117-207, 1980.
35. Hammad H, Higashi T, Tateishi N, Hanatani M, and Sakamoto Y: Lipid peroxidation in the liver of carcinogen-resistant rats. Biochim Biophys Acta 1045, 99-106, 1990.
36. Iyanagi T, Watanabe T, and Uchiyama Y: The 3-methylcholanthrene-inducible UDP-glucuronosyltransferase deficiency in the hyperbilirubinemic rat (Gunn rat) is caused by a -1 frameshift mutation. J Biol Chem 264, 21302-21307, 1989.
37. Hacker HJ, Moore MA, Mayer D, and Bannasch P: Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis 3, 1265-1272, 1982.
38. 3H-thymidine for studies of hepatocellular proliferation in rodents. Carcinogenesis 10, 1341-1343, 1989.
39. Dragon YP, Hully J, Crow R, Mass M, and Pitot HC: Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis. Carcinogenesis 15, 1939-1947, 1994.
40. Dahlaus M and Appel KE: N-Nitrosodimethylamine, N-nitrosodiethylamine, and N-nitrosomorpholine fail to generate 8-hydroxy-2′-deoxyguanosine in liver DNA of male F344 rats. Mutat Res 285, 295-302, 1993.
41. Park JW, Cundi KC, and Ames BN: Detection of DNA adducts by high-performance liquid chromatography with electrochemical detection. Carcinogenesis 10, 827-832, 1989.
42. Shen HM, Ong CN, Lee BL, and Shi CY: Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA. Carcinogenesis 16, 419-422, 1995.
43. Olive PL, Wlodek D, Duran RE, and Banath JP: Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp Cell Res 198, 259-267, 1992.
44. Bishayee A and Chatterjee M: Inhibitory effect of vanadium on rat liver carcinogenesis initiated with diethylnitrosamine and promoted by phenobarbital. Br J Cancer 71, 1214-1220, 1995.
45. Farber E and Cameron R: The sequential analysis of cancer development. Adv Cancer Res 31, 125-226, 1980.
46. Farber E: Clonal adaptation during carcinogenesis. Biochem Pharmacol 39, 1837-1846, 1990.
47. Magdalou J, Balland M, Thirion C, and Siest G: Effects of membrane perturbants on UDP-glucuronosyltransferase activity in rat-liver microsomes. Circular dichroism studies. Chem Biol Interact 27, 255-268, 1979.
48. Bannasch P, Hacker HJ, Klimek F, and Mayer D: Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul 22, 97-121, 1984.
49. Floyd RA: The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11, 1447-1450, 1990.
50. Cattley RC and Glover SE: Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization. Carcinogenesis 14, 2495-2499, 1993.
51. Kato T, Hasegawa R, Nakae D, Hirose M, Yamao M, et al.: Dose-dependent induction of 8-hydroxyguanine and prneoplastic foci in rat liver by food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoline at low dose levels. Jpn J Cancer Res 87, 127-133, 1996.
52. Floyd RA, West MS, Eneff KL, Hogsett WE, and Tingey DT: Hydroxyl free radical mediated formation of 8-hydroxyguanine in isolated DNA. Arch Biochem Biophys 262, 266-272, 1988.
53. Keyer K and Imlay JA: Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci USA 93, 13635-13640, 1996.
54. Hamilton EE and Wilker JJ: Inorganic oxo compounds react with alkylating agents: implications for DNA damage. Angew Chem Int Ed Eng 43, 3290-3292, 2004.
55. Hamilton EE and Wilker JJ: Inhibition of DNA alkylation damage with inorganic salts. J Biol Inorg Chem 9, 894-902, 2004.
56. Hamilton EE, Fanwick PE, and Wilker JJ: Alkylation of inorganic oxo compounds and insights on preventing DNA damage. J Am Chem Soc 128, 3388-3395, 2006.
57. Vamvakas S, Vock EH, and Lutz WK: On the role of DNA double-strand breaks in toxicity and carcinogenesis. Crit Rev Toxicol 27, 155-174, 1997.
58. Richardson C and Jasin M: Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405, 697-700, 2000.
59. Khanna KK and Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nature Genet 27, 247-254, 2001.
60. Ferguson DO and Alt FW: DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 20, 5572-5579, 2001.
61. Martín M, Genescà A, Latre L, Jaco I, Taccioli GE, et al.: Postreplicative joining of DNA double-strand breaks causes genomic instability in DNA-PKcs-deficient mouse embryonic fibroblasts. Cancer Res 65, 10223-10232, 2005.
62. Jackson SP: Sensing and repairing DNA double-strand breaks. Carcinogenesis 23, 687-696, 2002.
63. Boiteux S and Radicella JP: Base excision repair of 8-hydroxyguanine protects DNA from endogenous oxidative stress. Biochimie 81, 59-67, 1999.
64. Bohr VA and Dianov GL: Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 81, 155-160, 1999.
65. Zhang Z, Huang C, Li J, and Shi X: Vanadate-induced cell growth arrest is p53-dependent through activation of p21 in C141 cells. J Inorg Biochem 89, 142-148, 2002.
66. Oesch-Bartlomowicz B, Arnes HJ, Richter B, Hengstler JG, and Oesch F: Control of the mutagenicity of aromatic amines by protein kinases and phosphatases. I: the protein phosphates inhibitors okadaic acid and ortho-vanadate drastically reduced the mutagenicity of aromatic amines. Arch Toxicol 71, 601-611, 1997.
67. Padma PR, Oesch-Bartlomowicz B, Hengstler JG, and Oesch F: Control of the mutagenicity of arylamines by protein kinases and phosphatases: II. lack of response of rat liver N-acetyl transferases to phosphorylation modulators. Arch Toxicol 71, 655-659, 1997.